The Effects of Celecoxib on Bone Ingrowth in Porous Coated Titanium Ceramic Implants in Humans

Trial Profile

The Effects of Celecoxib on Bone Ingrowth in Porous Coated Titanium Ceramic Implants in Humans

Discontinued
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2016

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Osteoarthritis; Postoperative pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Sep 2008 Planned end date changed from 1 May 2009 to 1 Sep 2008 as reported by ClinicalTrials.gov.
    • 30 Sep 2008 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
    • 31 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top